Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?

The article focuses on the post-COVID-19 scenario regarding the availability of oncology drugs on both sides of the Atlantic, discussing the rising prevalence and causes of global medicine shortages, their significant impact on cancer care, and the resulting challenges for healthcare providers and patients. It emphasizes the urgent need for collaborative solutions at a global level to prevent and manage these shortages effectively.